# Lactobacillus delbrueckii subsp. bulgaricus R0092

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/lactobacillus-delbrueckii-subsp-bulgaricus-r0092
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-03
**Evidence Score:** 2 / 10
**Category:** Fermented/Probiotic
**Also Known As:** L. delbrueckii subsp. bulgaricus R0092, L. bulgaricus R0092, Lactobacillus bulgaricus R0092, Bulgarian bacillus R0092, Yogurt culture R0092, L. delbrueckii bulgaricus R0092

## Overview

Lactobacillus delbrueckii subsp. bulgaricus R0092 is a [probiotic](/ingredients/condition/gut-health) strain that produces lactic acid and exopolysaccharides, acting primarily by reinforcing intestinal epithelial barrier integrity and modulating mucosal immune responses. Its mechanisms include suppression of [pro-inflammatory cytokine](/ingredients/condition/inflammation) signaling and enhancement of mucin production to protect the gut lining.

## Health Benefits

• May support intestinal barrier function by suppressing cytokine-induced dysfunction and improving mucin production (in vitro evidence only)
• Potential weight management support based on one 12-week human trial using 1 × 10⁸ CFU daily (limited clinical evidence)
• May help reduce [inflammation](/ingredients/condition/inflammation) in atopic conditions like dermatitis (animal study evidence)
• Could protect against [oxidative stress](/ingredients/condition/antioxidant) and improve antioxidant indices in liver and kidney tissue (animal study evidence)
• May help maintain gut microbiota balance during stress conditions (animal study evidence)

## Mechanism of Action

L. delbrueckii subsp. bulgaricus R0092 exerts its effects partly by inhibiting cytokine-induced disruption of tight junction proteins such as occludin and claudin-1 in intestinal epithelial cells, thereby preserving paracellular barrier function. The strain also stimulates goblet cells to upregulate MUC2 mucin gene expression, thickening the mucus layer that separates luminal bacteria from host tissue. Additionally, its cell wall components and metabolites may interact with toll-like receptor 2 (TLR2) and TLR4 signaling pathways to downregulate NF-κB-mediated [pro-inflammatory cytokine](/ingredients/condition/inflammation) cascades including TNF-α and IL-6.

## Clinical Summary

A 12-week randomized human trial investigated daily supplementation with 1 × 10⁸ CFU of R0092 and reported potential support for weight management outcomes, though the study's sample size and full methodology have not been widely replicated. In vitro evidence supports the strain's ability to reduce cytokine-induced intestinal barrier dysfunction and improve mucin production, but these findings have not yet been confirmed in large-scale human trials. Evidence for [anti-inflammatory](/ingredients/condition/inflammation) effects remains preliminary, drawn primarily from cell culture or small-scale studies. Overall, the evidence base is considered limited and early-stage, with additional well-controlled clinical trials needed before strong efficacy claims can be made.

## Nutritional Profile

Lactobacillus delbrueckii subsp. bulgaricus R0092 is a bacterial strain delivered as a lyophilized (freeze-dried) powder, not a macronutrient source in the conventional sense. Its bioactive components include exopolysaccharides (EPS), which contribute to mucoadhesion and [immunomodulat](/ingredients/condition/immune-support)ion; cell wall peptidoglycans and lipoteichoic acids, which interact with intestinal toll-like receptors (TLR-2, TLR-4); and secreted metabolites including lactic acid (D- and L-isomers), bacteriocin-like inhibitory substances, and short-chain fatty acid precursors. The strain produces beta-galactosidase enzyme, aiding lactose hydrolysis in the gut. As a homofermentative lactic acid bacterium, it generates lactic acid as its primary fermentation end product. Clinical doses have been studied at 1 × 10⁸ CFU daily. Viability and bioavailability are highly dependent on delivery matrix (enteric coating, microencapsulation) and storage conditions; lyophilized forms retain greater viability at room temperature compared to liquid suspensions. No direct vitamin or mineral content is applicable at [probiotic](/ingredients/condition/gut-health) doses, though metabolic activity in the gut may contribute to minor B-vitamin synthesis (B12, folate) as a secondary ecological effect.

## Dosage & Preparation

The clinically studied human dosage is 1 × 10⁸ CFU daily administered as a powder for 12 weeks. This represents a standard [probiotic](/ingredients/condition/gut-health) dose, though dosage variations for different conditions have not been established. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

L. delbrueckii subsp. bulgaricus R0092 is generally regarded as safe for healthy adults, as Lactobacillus species have a long history of use in fermented foods such as yogurt. Individuals who are immunocompromised, critically ill, or have central venous catheters should consult a physician before use, as rare cases of bacteremia have been reported with [probiotic](/ingredients/condition/gut-health) strains in vulnerable populations. No significant drug interactions have been formally documented for this specific strain, though concurrent use with broad-spectrum antibiotics may reduce its viability and efficacy. Safety data during pregnancy and lactation is insufficient for this particular strain, and medical guidance is recommended before use in these populations.

## Scientific Research

The research includes one randomized controlled trial with 36 overweight participants receiving 1 × 10⁸ CFU daily for 12 weeks, though specific results were not detailed. Most evidence comes from animal models including studies on atopic dermatitis (PMID: 23548305), lead toxicity protection, and hypoxic injury mitigation in mice.

## Historical & Cultural Context

The research does not provide information about traditional or historical medicinal use of this strain. L. bulgaricus is documented primarily as a modern [probiotic](/ingredients/condition/gut-health) and dairy fermentation culture without established traditional medicine applications.

## Synergistic Combinations

R0092 pairs well with Lactobacillus acidophilus NCFM and Bifidobacterium longum BB536, as these strains occupy complementary niches in the small and large intestine respectively, creating additive colonization resistance and broader [immunomodulatory](/ingredients/condition/immune-support) coverage via distinct TLR signaling pathways. [Prebiotic](/ingredients/condition/gut-health) inulin-type fructooligosaccharides (FOS, 3–5g daily) or galactooligosaccharides (GOS) act as selective fermentation substrates that enhance R0092 metabolic activity and EPS production, amplifying its mucin-stimulating and barrier-protective effects — a classic synbiotic interaction. Additionally, pairing with zinc (10–15mg elemental) supports the intestinal tight junction proteins (claudin-1, occludin) that R0092 is proposed to upregulate, creating a complementary dual-pathway approach to barrier integrity that addresses both the microbial and micronutrient determinants of epithelial function.

## Frequently Asked Questions

### What is Lactobacillus delbrueckii bulgaricus R0092 used for?

R0092 is primarily studied for supporting intestinal barrier function, reducing gut inflammation, and potential weight management. In vitro research shows it suppresses cytokine-induced tight junction disruption and boosts MUC2 mucin production, while one 12-week human trial suggested a benefit for weight management at 1 × 10⁸ CFU per day.

### What is the recommended dosage of Lactobacillus delbrueckii bulgaricus R0092?

The only human clinical trial identified for this strain used a dose of 1 × 10⁸ CFU daily over 12 weeks. This is notably lower than doses used for many other probiotic strains, and no established consensus dosage exists beyond this single study. Always follow the manufacturer's label or a healthcare provider's guidance.

### How does Lactobacillus delbrueckii bulgaricus R0092 support gut health?

The strain supports gut health by preserving the integrity of intestinal tight junction proteins such as occludin and claudin-1 in the face of pro-inflammatory cytokines like TNF-α and IL-1β. It also stimulates MUC2 mucin secretion by goblet cells, fortifying the mucus layer that acts as a physical barrier against pathogens and luminal antigens.

### Is Lactobacillus delbrueckii bulgaricus R0092 safe to take daily?

For healthy adults, daily use is generally considered safe given the long history of L. delbrueckii subsp. bulgaricus in fermented dairy foods. However, immunocompromised individuals, those on immunosuppressive medications, or patients with serious underlying illnesses should seek medical advice before supplementing, as probiotic bacteremia, while rare, has been documented in high-risk groups.

### What is the difference between Lactobacillus delbrueckii bulgaricus R0092 and regular yogurt cultures?

While L. delbrueckii subsp. bulgaricus is the same species used as a standard yogurt starter culture, the R0092 designation refers to a specific proprietary strain with documented in vitro and clinical data tied to its unique genetic and functional characteristics. Strain-level differences can significantly affect probiotic activity, meaning that the R0092 strain may exert distinct effects on barrier function and immune modulation that are not necessarily shared by other bulgaricus strains found in commercial yogurt.

### What does the R0092 strain designation mean for Lactobacillus delbrueckii bulgaricus?

The R0092 designation is a proprietary strain identifier used to distinguish this specific isolate from other Lactobacillus delbrueckii bulgaricus strains in clinical research and formulations. This numbering system ensures consistency and traceability in studies, allowing manufacturers and researchers to reference the exact strain tested in clinical trials. Different strain designations may have varying functional properties, so the R0092 designation indicates this particular strain was used in the weight management and barrier function research referenced in the literature.

### Is Lactobacillus delbrueckii bulgaricus R0092 safe to take with antibiotics?

It is generally recommended to space probiotic supplements at least 2–3 hours apart from antibiotic medications to minimize potential interference with antibiotic effectiveness. Since antibiotics can significantly reduce beneficial bacteria populations, taking L. delbrueckii bulgaricus R0092 after completing your antibiotic course may help support gut flora recovery. Consult your healthcare provider about the optimal timing for this strain, as individual circumstances and antibiotic types vary.

### How strong is the clinical evidence supporting Lactobacillus delbrueckii bulgaricus R0092's health benefits?

The evidence for L. delbrueckii bulgaricus R0092 is mixed: while one 12-week human trial showed potential weight management support, most other benefits (intestinal barrier function, inflammation reduction, oxidative stress protection) are currently supported only by in vitro or animal studies. Human clinical trials are limited and more robust research is needed to establish definitive efficacy for these claimed benefits. When evaluating this strain, it is important to distinguish between preliminary laboratory evidence and clinically validated human outcomes.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*